The shingles vaccine is recommended for healthy adults age 50 or older, and also for anyone age 19 years or older who has a ...

and Medicare enrollees paid an average of $77 for the shingles vaccine. But the Inflation Reduction Act changed the rules, and recommended vaccines are now available at no cost, even if you haven't ...

The research report from Fosun International Securities indicates that AIM's technology route successfully avoids the patent barriers of existing shingles vaccines, creating favourable conditions ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

Measles is a respiratory disease caused by a highly contagious virus that's more infectious than influenza, chickenpox or COVID-19.

and Acharya said that 10% to 20% of those cases will involve shingles of the eye. The clinical trials that test vaccines can tell researchers whether a shot will generally be effective at ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Prominent outside scientists who help the NIH evaluate its internal research programs are being abruptly removed ...

To combat the rising cases of shingles, a particular scourge for older adults, the health ministry will add its vaccination to the national immunization program, starting in fiscal 2025.

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

during which he helped shape its vaccine business by contributing to the creation of numerous new vaccines including Shingrix ® (shingles), Cervarix ® (HPV-induced cervical cancer), Mosquirix ® ...